62 related articles for article (PubMed ID: 16229896)
1. CpG-oligodeoxynucleotide is a potent adjuvant with an Entamoeba histolytica Gal-inhibitable lectin vaccine against amoebic liver abscess in gerbils.
Ivory CP; Keller K; Chadee K
Infect Immun; 2006 Jan; 74(1):528-36. PubMed ID: 16369009
[TBL] [Abstract][Full Text] [Related]
2. Herpes simplex virus type 2 vaccines: new ground for optimism?
Aurelian L
Clin Diagn Lab Immunol; 2004 May; 11(3):437-45. PubMed ID: 15138167
[TBL] [Abstract][Full Text] [Related]
3. CpG motif acts as a 'danger signal' and provides a T helper type 1-biased microenvironment for DNA vaccination.
Liu L; Zhou X; Liu H; Xiang L; Yuan Z
Immunology; 2005 Jun; 115(2):223-30. PubMed ID: 15885128
[TBL] [Abstract][Full Text] [Related]
4. Towards an effective genital herpes vaccine: past lessons and future prospects.
Halford WP
Future Virol; 2007 Jan; 2(1):1-6. PubMed ID: 23843891
[No Abstract] [Full Text] [Related]
5. The MSHA strain of Pseudomonas aeruginosa activated TLR pathway and enhanced HIV-1 DNA vaccine immunoreactivity.
Hou J; Liu Y; Liu Y; Shao Y
PLoS One; 2012; 7(10):e47724. PubMed ID: 23077664
[TBL] [Abstract][Full Text] [Related]
6. New concepts in herpes simplex virus vaccine development: notes from the battlefield.
Dasgupta G; Chentoufi AA; Nesburn AB; Wechsler SL; BenMohamed L
Expert Rev Vaccines; 2009 Aug; 8(8):1023-35. PubMed ID: 19627185
[TBL] [Abstract][Full Text] [Related]
7. The mast cell activator compound 48/80 is safe and effective when used as an adjuvant for intradermal immunization with Bacillus anthracis protective antigen.
McGowen AL; Hale LP; Shelburne CP; Abraham SN; Staats HF
Vaccine; 2009 Jun; 27(27):3544-52. PubMed ID: 19464533
[TBL] [Abstract][Full Text] [Related]
8. A genital tract peptide epitope vaccine targeting TLR-2 efficiently induces local and systemic CD8+ T cells and protects against herpes simplex virus type 2 challenge.
Zhang X; Chentoufi AA; Dasgupta G; Nesburn AB; Wu M; Zhu X; Carpenter D; Wechsler SL; You S; BenMohamed L
Mucosal Immunol; 2009 Mar; 2(2):129-143. PubMed ID: 19129756
[TBL] [Abstract][Full Text] [Related]
9. Prophylactic vaccine strategies and the potential of therapeutic vaccines against herpes simplex virus.
Ferenczy MW
Curr Pharm Des; 2007; 13(19):1975-88. PubMed ID: 17627531
[TBL] [Abstract][Full Text] [Related]
10. The potential of immunostimulatory CpG DNA for inducing immunity against genital herpes: opportunities and challenges.
Harandi AM
J Clin Virol; 2004 Jul; 30(3):207-10. PubMed ID: 15135735
[TBL] [Abstract][Full Text] [Related]
11. Vaccination strategies to prevent genital herpes and neonatal herpes simplex virus (HSV) disease.
Jones CA; Cunningham AL
Herpes; 2004 Apr; 11(1):12-7. PubMed ID: 15115632
[TBL] [Abstract][Full Text] [Related]
12. CpG oligodeoxynucleotide augments HSV-2 glycoprotein D DNA vaccine efficacy to generate T helper 1 response and subsequent protection against primary genital herpes infection in mice.
Tengvall S; Josefsson A; Holmgren J; Harandi AM
J Reprod Immunol; 2005 Dec; 68(1-2):53-69. PubMed ID: 16229896
[TBL] [Abstract][Full Text] [Related]
13. Rectal immunization generates protective immunity in the female genital tract against herpes simplex virus type 2 infection: relative importance of myeloid differentiation factor 88.
Tengvall S; O'Hagan D; Harandi AM
Antiviral Res; 2008 Jun; 78(3):202-14. PubMed ID: 18276020
[TBL] [Abstract][Full Text] [Related]
14. Nasal and skin delivery of IC31(®)-adjuvanted recombinant HSV-2 gD protein confers protection against genital herpes.
Wizel B; Persson J; Thörn K; Nagy E; Harandi AM
Vaccine; 2012 Jun; 30(29):4361-8. PubMed ID: 22682292
[TBL] [Abstract][Full Text] [Related]
15. Intravaginal immunization with viral subunit protein plus CpG oligodeoxynucleotides induces protective immunity against HSV-2.
Kwant A; Rosenthal KL
Vaccine; 2004 Aug; 22(23-24):3098-104. PubMed ID: 15297061
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
